Related by context. Frequent words. (Click for all words.) 76 Inc Therapeutic Competitors 75 Inc. Nasdaq IMGN 74 DVAX 74 Cyclacel Pharmaceuticals 74 www.syntapharma.com 73 ENZN 73 Idera Pharmaceuticals 73 NASDAQ CRXL 73 Presents Positive 72 IMGN 72 Transcept Pharmaceuticals 72 www.combinatorx.com 72 Nasdaq VRTX 72 Metabasis Therapeutics 72 R sorafenib tablets 71 IMMU 71 CRTX 71 Bayhill Therapeutics 71 Inc. NASDAQ TRGT 71 ABII 71 Nasdaq ENZN 71 AUXL 71 NASDAQ CYPB 71 www.celgene.com 71 Advancing Drugs 70 ACADIA Pharmaceuticals 70 Nasdaq ALTH 70 NASDAQ LGND 70 Crucell NV Euronext 70 Sunesis Pharmaceuticals 70 Files Shelf Registration Statement 70 Barrier Therapeutics Inc. 70 addressing idiopathic pulmonary 70 NovaBay Pharmaceuticals Inc. 70 LXRX 70 Metabasis Therapeutics Inc. 70 ImmunoGen Inc. 70 VIA Pharmaceuticals 70 Inc. NASDAQ RRGB 70 OPTR 70 Genaera Corporation 69 Rigel Pharmaceuticals 69 DYAX 69 refractory chronic lymphocytic 69 www.polymedix.com 69 www.delcath.com 69 CRXX 69 SGMO 69 PYMX 69 Completes Enrollment 69 http:/www.exelixis.com 69 Nasdaq BIIB 69 SGEN 69 By Thomas Gryta 69 Calls Purchased 69 www.schering plough.com 69 www.exelixis.com 69 NASDAQ ARIA 69 ISTA Pharmaceuticals 69 VRUS 69 www.allos.com 69 BPAX 69 Connetics Corporation 69 INCY 69 Ardea Biosciences 69 CoTherix Inc. 68 OncoGenex Pharmaceuticals Inc. 68 Rexahn Pharmaceuticals 68 Sunesis Pharmaceuticals Inc. 68 EntreMed Inc. 68 Harbor BioSciences 68 Nasdaq REGN 68 Trubion Pharmaceuticals 68 Acadia Pharmaceuticals 68 Progenics Pharmaceuticals 68 Rexahn Pharmaceuticals Inc. 68 Report companiesandmarkets.com adds 68 Altus Pharmaceuticals 68 Peregrine Pharmaceuticals Inc. 68 Fibrocell Science Inc. 68 Nasdaq ISIS 68 www.questcor.com 68 NASDAQ OSIR 68 novel antibody therapeutics 68 Pharmion Corporation 68 Ardea Biosciences Inc. 68 AVEO Pharmaceuticals 68 EPIX Pharmaceuticals Inc. 68 NASDAQ DYAX 68 Nasdaq ATEC 68 www.cardiome.com 68 MLNM 68 NovaBay Pharmaceuticals 68 Nektar Therapeutics NKTR 68 AEterna Zentaris Inc. 68 BioMarin Pharmaceutical 68 Halozyme Therapeutics 68 MKC# 68 IDIX 68 Initiates Phase 67 Opexa Therapeutics Inc.